Toxicity and Safety of Induction Chemotherapy in Locally Advanced Oropharynx, Hypopharynx and Larynx: Non-Randomized Study Comparing DCF and Immunochemotherapy (ICT) with PF-Pembrolizumab. Вопр. онкол. [Internet]. 2025 Jan. 22 [cited 2026 Oct. 15];70(6):1096-105. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/6-24-Toxicity